As UK MedTech policy continues to evolve, BHTA members have an important opportunity to hear directly from Paul Griffiths, Head of Policy and Implementation, MedTech Directorate, at the BHTA Joint Section Meeting 2026.
Paul will deliver the opening keynote, ‘UK MedTech Strategy Update’, exploring the latest developments shaping UK MedTech policy, innovation adoption, procurement reform, and implementation priorities. The session will provide valuable insight into the strategic direction of the sector and what future policy developments could mean for healthcare businesses.
Ahead of the event, the BHTA spoke with Paul about the key policy updates members should be aware of and why his session will be valuable.
BHTA: What are the key MedTech policy updates that BHTA members should be aware of in 2026?
Paul Griffiths: “We are seeing continued delivery of key programmes of the NHS 10 Year Plan and the Life Sciences Sector Plan. Recent highlights include publication of the Value Based Procurement Standard Guidance and the start of the Wave 1 Part IX Drug Tariff renewal assessments.”
BHTA: What does the latest direction of UK MedTech policy mean for healthcare businesses?
Paul Griffiths: “Increased clarity and less friction making the UK, and the NHS in particular, a more attractive place to invest and innovate.”
BHTA: How is the government looking to improve the adoption of innovative MedTech?
Paul Griffiths: “A significant amount of work is underway to improve the way we adopt innovative MedTech. You only have to see progress on developing the National Health Tech Access Programme, standard guidance on Value Based Procurement, and the work on regulatory reform, to see we are committed to driving improvement.”
BHTA: Why should BHTA members attend your session at the Joint Section Meeting?
Paul Griffiths: “This will be an opportunity to get the latest updates and development on policy in the MedTech space.”
BHTA: Will you be sharing any new updates or insights that have not previously been discussed publicly?
Paul Griffiths: “Information is in public domain, for example the recent publication of Value Based Procurement standard guidance.”
For BHTA members, these topics have real relevance. From procurement and regulatory reform to innovation adoption, and NHS priorities, Paul’s keynote will help members better understand the direction of travel for UK MedTech policy.
The BHTA Joint Section Meeting 2026 takes place on 18 June at the British Motor Museum, Warwickshire. Free to attend for BHTA members, the event will bring together members from across all sections for a day of insight, collaboration, and networking.
Alongside Paul’s opening keynote, the agenda includes expert sessions covering employment law, housing adaptations, disability inclusion, market intelligence, and wider healthcare sector trends.
Don’t miss the opportunity to hear from Paul directly and gain valuable insight into the policy developments shaping the future of the sector.